• Hospital expansion timeline: Dombivli is expected to reach EBITDA break-even in Year 2 after estimated losses of ₹2–3 crore per month in Year 1. Upcoming openings in South Pune (2028), Mira Road (2029), and BKC are staggered so existing mature hospitals can absorb margin dilution.
• BKC market positioning: Management views the upcoming BKC facility as addressing a significant supply vacuum in Mumbai for organized, high-quality healthcare rather than entering an intensely competitive market.
• Hospital growth drivers: Thane's growth is expected to align solely with inflation, while Pune retains upside from expanding occupancy from the high 60% range to the mid-70% range. Indore and Dombivli retain additional ARPOB growth levers via case-mix improvements toward tertiary and quaternary care.
• Asset-heavy strategy: The company remains committed to an owned-and-operated, asset-heavy real estate model, maintaining that fully owned assets deliver superior long-term life-cycle performance in an inflationary economy.